Here are some questions I'd like to see answered t
Post# of 148166
1. Number of deaths in study group vs. placebo at 28 days?
2. Have we had the review meeting regarding guidance for filing the BLA for HIV? If not why not? How many months are we supposed to wait for a meeting?
3. Do we compensate each study site according to how many test subjects are entered into the study? Can you give any insight on why we have recently had a decreased rate of enrollment?
4. Status of HIV stem cell cure for patients? This seems like it would be important to know because just one or two patients could make world wide headlines.